BSD Medical has over 40 employees who provide a broad complement of management, technical, regulatory, sales/marketing, production, financial and administrative skills.

The Board of Directors and certain key officers and employees are as follows:

The members of the Company’s Board of Directors are as follows:

Timothy C. McQuay, MBA, has served as a director of BSD since February 2008 and was appointed Chairman of the Board in May 2009. He is a Managing Director with B Riley & Co., a Los Angeles based investment banking firm. Prior to joining B Riley in September 2008, Mr. McQuay served for ten years as Managing Director Investment Banking at A. G. Edwards & Sons, Inc., where he specialized in Healthcare, including medical technology, biotechnology and specialty pharmaceuticals. He previously served as Partner and Managing Director Investment Banking at Crowell, Weedon & Company; as Vice President Corporate Development at Kerr Group, Inc.; as Managing Director Merchant Banking at Union Bank of California; as Senior Vice-President Corporate Finance at Wedbush Morgan Securities, and as Vice-President Brokerage Services at Alexander & Alexander, Inc. Mr. McQuay holds an AB in Economics from Princeton University and an MBA from UCLA.

Gerhard W. Sennewald, Ph.D.,, has served as a director of BSD since 1994. From April 1985 to the present, Dr. Sennewald has served as the President and Chief Executive Officer of Medizin-Technik GmbH, of Munich, Germany, a firm which is engaged in the business of distributing hyperthermia equipment and diagnostic imaging equipment and services. In connection with his service to Medizin-Technik GmbH, Dr. Sennewald has been BSD’s key European representative and distributor for 17 years and has been instrumental in obtaining the majority of BSD’s foreign sales. He also serves on the Board of Directors of TherMatrx, Inc.

Michael Nobel, Ph.D., has served as a director of BSD since January 1998. Dr. Nobel participated in the introduction of magnetic resonance imaging as European Vice President of Fonar Corp. From 1991 to 2007, Dr. Nobel served as the Executive Chairman of the MRAB Group, a company providing diagnostic imaging services to Sweden. From 1995 to 2006, Dr. Nobel was Chairman of the Board of the Nobel Family Society and the American Non-Violence Project Inc. He has also been a consultant to Unesco in Paris and the United Nations Social Affairs Division in Geneva. Today, Dr. Nobel is chairman or board member of ten international companies in medical diagnostics, treatment and information systems; other areas included banking, IT, oil exploration and environmental management. He is visiting professor at the Tokyo Institute of Technology in Japan.

Douglas P. Boyd, Ph.D., has served as a director of BSD since 2005. From January 2007 to the present, Dr. Boyd has served as Chief Executive Officer of TeleSecurity Sciences, Inc., a privately-held company in the business of developing solutions for increasing the effectiveness and automation of airport explosives detection systems. From 1983 to 2005, Dr. Boyd was an adjunct professor of radiology at the University of California, San Francisco. From 1980 to 2004, Dr. Boyd served as Chairman of the Board, Chief Executive Officer and Chief Technology Officer of Imatron Inc., a public company that developed and manufactured ultrafast electron beam CT scanners for use in hospitals and clinics. He is internationally known as an expert in radiology and computed tomography (“CT”) imaging systems, and has pioneered the development of fan-beam CT scanners, Xenon detector arrays and EBT scanners. Dr. Boyd has been awarded 16 U.S. patents. He has published more than 100 scientific papers and is a frequent speaker at universities and symposia.

Steven G. Stewart has served as a director of BSD since 2006. He is currently the Chief Financial Officer for Headwaters, Inc. (a New York Stock Exchange company). Mr. Stewart served as Headwaters’ Chief Financial Officer from July 1998 until October 2005 when he became the Treasurer and subsequently the Director of Financial Affairs. He was re-appointed as the Chief Financial Officer of Headwaters on September 4, 2007. Prior to joining Headwaters, Mr. Stewart served as a business assurance partner for PricewaterhouseCoopers LLP (formerly Coopers & Lybrand LLP), and as an audit partner with Ernst & Young (formerly Arthur Young), including service as the Salt Lake City office Director of High Technology and Entrepreneurial Services.

Harold R. Wolcott was appointed a director and President in April 2009. He has 40 years experience managing and growing newly-formed venture capital financed corporations as well as multi-million dollar medical device businesses with international operations. He has a wide range of experience in the areas of product research, product engineering, manufacturing and plant management, as well as expertise in all aspects of sales and marketing, acquisition/integration and the sale of medical device businesses. Prior to joining the Company, Mr. Wolcott served for a period of time as President and Chief Operating Officer and later as Director of Dimicron Inc., a development stage medical company utilizing synthetic diamond for orthopedic applications, from August 2006 until March 2009. From March 2001 until June 2005, Mr. Wolcott served as Chief Operating Officer and Director of Rubicon Medical, Inc., a company focusing on proprietary technology in embolic protection for interventional cardiology and interventional neurology.

Paul F. Turner, MSEE, has served as a director of BSD since 1994. Mr. Turner also has served as the Senior Vice President and Chief Technology Officer of BSD since August 1999. From October 1995 to August 1999, Mr. Turner served as the Acting President of BSD. From 1978 to October 1995, Mr. Turner served in various capacities with BSD, including Staff Engineer, Staff Scientist, Senior Scientist, Vice President of Research, and Senior Vice President of Research. Mr. Turner has led the design of microwave treatment systems for tumors, including the development of external phased array antenna technology to focus radiated microwave energy deep into the central area of the body to treat deep tumors. He has also integrated this technology with magnetic resonance imaging to non-invasively monitor treatments within the patient’s body.

Other officers and key employees are as follows:

Dennis P. Gauger, CPA (Chief Financial Officer / Secretary), has served as Chief Financial Officer since May 2007. Mr. Gauger is a licensed Certified Public Accountant in Utah and Nevada. He has led our Sarbanes – Oxley internal controls compliance and manages our external financial and SEC reporting. He also directs our investor relations activities, including press releases and investor communications. Prior to his full time employment with BSD Medical Corporation, he served several public and private companies in a variety of industries as a part-time, contract financial executive, corporate troubleshooter and consultant. Previously, Mr. Gauger worked for Deloitte & Touche LLP, an international accounting and consulting firm, for 22 years, including 9 years as an accounting and auditing partner. He is a member of the American Institute of Certified Public Accountants and the Utah Association of Certified Public Accountants.

Dixie Toolson Sells (VP Regulatory Affairs) joined BSD Medical in 1978 and has directed the Company’s regulatory affairs since 1984. During her tenure at BSD, Ms. Sells has been instrumental in obtaining fifty-one approvals from the FDA, including thirteen Pre-marketing (PMA) approvals, (both original PMA approvals and supplemental approvals for significant product changes), two 510(k) approvals, and twenty-six Investigational Device Exemption (IDE) approvals for a variety of medical devices and clinical studies. Ms. Sells has extensive experience in the conduct and monitoring of clinical studies. Prior to joining BSD, Ms. Sells held senior management positions for medical, technical consulting, and computer development companies and was responsible for the development and implementation of the business processes for these companies. She also served as editor for a number of technical publications. Ms. Sells serves on the Board of Directors of the Utah Intermountain Biomedical Association.

Brian L. Ferrand (VP of Sales) joined BSD Medical in 2005 as Vice President of Sales. Previously, Mr. Ferrand served from 1993 until October 2004 as Vice President of Sales and as a corporate officer of Merit Medical Systems, Inc. (a company traded on NASDAQ). Previously, Mr. Ferrand served as Director of Sales from 1992 to 1993 and as a National Sales Manager from 1991-1992 for Merit Medical. Merit Medical Systems is a producer of medical products used in cardiology and radiology sold on a worldwide basis.

Richard A. White, MBA, (VP of International Sales) joined BSD Medical in February 2005 after serving as an outside consultant. Mr. White has been involved in business development and growth since obtaining his degree in international business at The Garvin School of International Management "Thunderbird" in 1980. He has played a key role in the founding of new companies, has led a national sales organization selling large capital equipment in power control systems and served as International Sales Manager for Merit Medical Systems, a leading manufacturer and marketer of products used in diagnostic and interventional cardiology and radiology procedures.

Steven M. Smith (VP of Marketing and Business Development) joined BSD Medical in June 2009. Mr. Smith has 32 years of experience in the medical industry, with expertise in marketing, sales, new business development, product research and development, operations and corporate management. He most recently served as Director, Business Development, for Bard Access Systems, Inc., a division of C.R. Bard. Mr. Smith’s responsibilities at BSD Medical will include market analysis, product positioning, leveraging of existing technologies, new product launches and promotional activities.

Todd H. Turnlund (VP of Engineering) joined BSD Medical in January 2010. Mr. Turnlund has over 20 years of medical device experience with both medical device start up and Fortune 500 companies. His expertise includes translating unmet clinical needs into commercially successful products, creating intellectual property, developing new technology, and transferring product designs to manufacturing. He has served in various research and development management positions with Precision Vascular Systems, Boston Scientific, IsoStent, and Guidant. He has a Mechanical Engineering Degree from the University of California at Santa Barbara, and an MBA from Santa Clara University. He has over 30 issued and pending US Patents. Mr. Turnlund¹s responsibilities at BSD Medical will involve day to day management of the engineering team, including project management, electrical engineering, software engineering, mechanical engineering and document control.

Certain statements in the web site that relate to the future performance of BSD Medical Corporation or therapies performed on our equipment are "forward-looking" and are subject to risks and uncertainties inherent in our business that could cause actual results to differ materially from the statements. BSD Medical Corp. does not undertake responsibility to update such forward-looking statements. A detailed discussion of risks and uncertainties may be found in our Annual Report on Form 10-K and other documents filed with the Securities and Exchange Commission. Our recent SEC filings are available from this web site. BSD Medical Corporation is not responsible for nor do we endorse claims made on links included on our website.